No-fault compensation programme for COVID-19 vaccines is a world first
The World Health Organization (WHO) and Chubb Limited (NYSE: CB), through ESIS Inc., a Chubb company, signed an agreemen...
You are offline
Good Health and Well-being
91.6% Efficacy, Rare Adverse Effects: All You Need to Know About The Russian Sputnik V Vaccine
Russia’s COVID-19 vaccine Sputnik V on Monday received approval of Centre’s expert panel for emergency use in India with certain conditions. The Drugs Controller General of India (DCGI) will take a final call on the recommendation of the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO), which took up the application of Dr Reddy’s Laboratories seeking emergency use authorisation for Sputnik V.If approved, the vaccine would be imported from Russia for emergency use in the country. It will be the third COVID-19 vaccine to be available in India. The DCGI has given the emergency use authorisation for two COVID-19 vaccines — Covaxin of Bharat Biotech and Covishield of Oxford-AstraZeneca, being manufactured by Serum Institute of India in Pune.
View SourceRelated Notices
AstraZeneca’s vaccine woes grow on clots, nationalism, efficacy
AstraZeneca Plc’s vaccine for Covid-19, once expected to be a mainstay of protection for much of the world, remains s...
Bharat Biotech to pay compensation if Covaxin causes side effects
Hyderabad based firm Bharat Biotech on Saturday informed that the company will pay compensation to the recipients in cas...
This notice has been removed
The content is no longer available
91.6% Efficacy, Rare Adverse Effects: All You Need to Know About The Russian Sputnik V Vaccine
Russia’s COVID-19 vaccine Sputnik V on Monday received approval of Centre’s expert panel for emergency use in India with certain conditions. The Drugs Controller General of India (DCGI) will take a final call on the recommendation of the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO), which took up the application of Dr Reddy’s Laboratories seeking emergency use authorisation for Sputnik V.If approved, the vaccine would be imported from Russia for emergency use in the country. It will be the third COVID-19 vaccine to be available in India. The DCGI has given the emergency use authorisation for two COVID-19 vaccines — Covaxin of Bharat Biotech and Covishield of Oxford-AstraZeneca, being manufactured by Serum Institute of India in Pune.
Recent Searches
Recent Noticeboards
Trending
No results found
Try a different search term
Something went wrong
No notices yet
No notices match these filters
Couldn't load notices
You're all caught up 🎉
Discussion (0)
No comments yet